Statistics
Publications
10
Citations
651
H-Index
10
Active since
2007
Volker Schulze is an author at Bayer (Germany) specializing in pharmacology, medicine, and oncology.
Publications per year
2007–2025
10
10
Novel Mps1 Kinase Inhibitors with Potent Antitumor Activity
Antje M. Wengner, Gerhard Siemeister, Marcus Koppitz et al. · Molecular Cancer Therapeutics · 2016 · 118 citations · Full text
Medicine, Oncology, Pharmacology +17
Characterization of novel MPS1 inhibitors with preclinical anticancer activity
Mohamed Jèmaà, Lorenzo Galluzzi, Oliver Kepp et al. · Cell Death and Differentiation · 2013 · 111 citations · Full text
Medicine, Oncology, Pharmacology +14
Discovery of BAY-985, a Highly Selective TBK1/IKKε Inhibitor
Julien Lefranc, Volker Schulze, R.C. Hillig et al. · Journal of Medicinal Chemistry · 2019 · 47 citations · Full text
1–5 of 10